Seattle, WA, United States of America

Darrell C Conklin

USPTO Granted Patents = 63 

 

Average Co-Inventor Count = 2.4

ph-index = 12

Forward Citations = 488(Granted Patents)

Forward Citations (Not Self Cited) = 457(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Seattle, WA (US) (1999 - 2013)
  • London, GB (2011 - 2013)

Company Filing History:


Years Active: 1999-2013

Loading Chart...
Loading Chart...
Areas of Expertise:
Cytokine Receptor Zalpha11
FGF Homologs
Mammalian Cytokine-like Polypeptide-10
Antibodies to Cytokine Receptor
Polynucleotide Encoding Cytokine Receptor
Human Serine Protease
Kunitz Domain Polypeptide
Testis-specific Insulin Homologs
Interferon-epsilon
Zinsi Polypeptide Composition
Beta-1,3-galactosyltransferase Homologs
63 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Darrell C Conklin - Pioneering Biomedical Researcher from Seattle

Introduction

Darrell C Conklin is a renowned inventor based in Seattle, Washington, with a remarkable portfolio of 63 patents to his name. His groundbreaking work in the field of biomedical research has significantly advanced the development of innovative therapies and diagnostic tools.

Latest Patents

Conklin's latest patents showcase his expertise in the realm of cytokine research. One of his recent inventions includes an Antibody to human zcyto-10 polypeptide, designed to accelerate wound healing and platelet proliferation. Additionally, his Methods for producing cytokine receptor ZALPHA11 have paved the way for detecting ligands that stimulate cell growth and identifying genetic markers for human diseases.

Career Highlights

Currently affiliated with Zymogenetics, Inc., a prominent biotechnology company, Conklin has dedicated his career to pushing the boundaries of scientific discovery. His relentless pursuit of excellence has led to numerous breakthroughs that hold immense promise for the medical community and beyond.

Collaborations

Throughout his professional journey, Conklin has collaborated with accomplished peers such as Betty A Haldeman and Theresa A Deisher. Their collective efforts have not only enhanced the quality of research but also fostered a culture of innovation and collaboration within the field.

Conclusion

In conclusion, Darrell C Conklin stands as a trailblazer in the realm of biomedical inventions, with a prolific track record of patents and a commitment to advancing scientific knowledge. His contributions have not only transformed the way we approach healthcare but also inspire future generations of inventors to push the boundaries of what is possible in the world of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…